SXP
Lupin acquires Australia's Southern Cross PharmaAs a part of the transaction, Lupin's Australia subsidiary Generic Health will gain access to over 60 registered products having sales of o...30 Jul, 2021, 01.04 PM IST
Strong earnings growth to bolster valuations of SISThe company management projected 25 per cent revenue growth for the next three years.22 May, 2018, 10.30 AM IST
We have three ongoing M&A conversations in advanced stages: Rituraj Sinha, SIS IndiaMost of the customers we are dealing with now prefer operators who are completely GST compliant20 Dec, 2017, 03.52 PM IST
Load More